Literature DB >> 3139144

Effect of amiodarone on circulating antithyroid antibodies.

M Safran1, E Martino, F Aghini-Lombardi, L Bartalena, S Balzano, A Pinchera, L E Braverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3139144      PMCID： PMC1833860          DOI： 10.1136/bmj.297.6646.456

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.

Authors:  E Monteiro; A Galvão-teles; M L Santos; L Mourão; M J Correia; J Lopo Tuna; C Ribeiro
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

2.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.

Authors:  E Martino; M Safran; F Aghini-Lombardi; R Rajatanavin; M Lenziardi; M Fay; A Pacchiarotti; N Aronin; E Macchia; C Haffajee
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

3.  Amiodarone: a common source of iodine-induced thyrotoxicosis.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; L Bartalena; L Braverman; A Pinchera
Journal:  Horm Res       Date:  1987
  3 in total
  5 in total

1.  The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Authors:  L Tomisti; C Urbani; G Rossi; F Latrofa; C Sardella; L Manetti; I Lupi; C Marcocci; L Bartalena; O Curzio; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2016-01-13       Impact factor: 4.256

Review 2.  Amiodarone and the thyroid: a 2012 update.

Authors:  F Bogazzi; L Tomisti; L Bartalena; F Aghini-Lombardi; E Martino
Journal:  J Endocrinol Invest       Date:  2012-03-19       Impact factor: 4.256

3.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

4.  Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.

Authors:  E Martino; S Balzano; L Bartalena; A Loviselli; V Sica; L Petrini; L Grasso; M Piga; L E Braverman
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

Review 5.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.